Summary There are few large‐scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24 553 patients with Hashimoto’s disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67 years (range, 27–90 years). The pathological diagnosis of PTL patients included diffuse large B‐cell lymphoma (DLBCL) (n = 74), DLBCL with mucosa‐associated lymphoid tissue (MALT) lymphoma (n = 13), MALT lymphoma (n = 80) and others (n = 4). Of the 167 patients with B‐cell lymphoma, treatment included combined modality therapy (CMT) (n = 95), radiation therapy (RT) alone (n = 60) and chemotherapy alone (n = 6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97%) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5‐year overall survival rate was 85% (95% confidence interval, 79–91%). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.
Electrons are accelerated to nonthermal energies at shocks in space and astrophysical environments. While shock drift acceleration (SDA) has been considered a key process of electron acceleration at Earth’s bow shock, it has also been recognized that SDA needs to be combined with an additional stochastic process to explain the observed power-law energy spectra. Here, we show mildly energetic (∼0.5 keV) electrons are locally scattered (and accelerated while being confined) by magnetosonic-whistler waves within the shock transition layer, especially when the shock angle is large ( ). When measured by the Magnetospheric Multiscale mission at a high cadence, ∼0.5 keV electron flux increased exponentially in the shock transition layer. However, the flux profile was not entirely smooth and the fluctuation showed temporal/spectral association with large-amplitude ( ), low-frequency ( where is the cyclotron frequency), obliquely propagating ( , where is the angle between the wave vector and background magnetic field) whistler waves, indicating that the particles were interacting with the waves. Particle simulations demonstrate that, although linear cyclotron resonances with ∼0.5 keV electrons are unlikely due to the obliquity and low frequencies of the waves, the electrons are still scattered beyond 90° pitch angle by (1) resonant mirroring (transit-time damping), (2) non-resonant mirroring, and (3) subharmonic cyclotron resonances. Such coupled nonlinear scattering processes are likely to provide the stochasticity needed to explain the power-law formation.
We have examined ponderomotive acceleration/ion cyclotron resonance (PA/ICR) of argon ions by performing test particle simulations. The PA gives rise to the pure parallel acceleration of ions, while the ICR causes the perpendicular ion heating followed by the energy conversion from the perpendicular to the parallel direction in the presence of a divergent background magnetic field. The energy gain by the PA/ICR is classified in terms of the adiabatic parameter, Λ = L B Ω 0 /v 0|| , where L B is the axial divergent scale length of the background magnetic field, Ω 0 is the ion gyrofrequency at the resonance, and v 0|| is the initial ion drift velocity along the axial magnetic field. For Λ < 100, the energy gain, Δ , due to the PA/ICR increases as Λ increases. For Λ > 100, Δ saturates since the increased axial velocity of the ion via the PA reduces the transit time to cross the acceleration region. When the externally applied rf electric field intensity is increased to 1000 V/m, we find a maximal 60% increase in the energy gain for the PA/ICR scheme compared with the energy gain by the ICR only. We have applied the PA/ICR scheme to the next-generation electric thruster, and have estimated the thrust including ion wall-loss and ion-neutral collisions.
Context Slight elevations in plasma glucose (PG) manifest in advance of diabetes onset, but abnormalities in immunoreactive insulin (IRI), proinsulin (Pro), and adiponectin dynamics during this stage remain poorly understood. Objective The objective of this work is to investigate whether IRI and Pro dynamics become abnormal as glucose tolerance deteriorates from within the normal range toward impaired glucose tolerance (IGT), as well as the relationship between PG, and these dynamics and serum adiponectin levels. Design A cross-sectional study was designed. Setting This study took place at Jichi Medical University in Japan. Participants and Measurements PG, IRI, and Pro levels were determined in 1311 young Japanese individuals (age < 40 years) with normal or IGT before and at 30, 60, and 120 minutes during a 75-g oral glucose tolerance test. Participants were assigned to 4 groups according to glucose tolerance, and then background factors, adiponectin levels, insulin sensitivity (SI), and insulin secretion (β) indexes were determined. Results PG levels as well as IRI and Pro levels 60 and 120 minutes after glucose-loading increased incrementally with deteriorating glucose tolerance. All measures of β and the SI measure index of insulin sensitivity (ISI)-Matsuda decreased incrementally. Serum adiponectin levels were not significantly different among the glucose tolerance groups, but were independently and negatively correlated with fasting glucose. Conclusions Early β decreased and postloading Pro levels became excessive in a progressive manner as glucose tolerance deteriorated from within the normal range toward IGT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.